Researchers at the Cross Cancer Institute in Edmonton, Alberta, have come up with a relatively high-throughput way to analyze proteins that have covalently cross-linked to DNA due to radiation exposure.
The research aims to shed light on the cytotoxic effects of radiation used in the treatment of cancer, explained Sharon Barker, the lead author of a study describing the new method that was published in last week's issue of Analytical Biochemistry.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
